Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation inhibitors in neurology

A Keyser1

  • 1Institute of Neurology, St. Radboud University Hospital, Catholic University Nijmegen, The Netherlands.

Pharmacy World & Science : PWS
|December 17, 1993
PubMed
Summary

Secondary prevention of ischaemic stroke focuses on preventing brain infarction. Antiplatelet drugs like acetylsalicylic acid offer modest benefits, with dipyridamole potentially enhancing efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing owner reported and genetic breed identification reveals high concordance in a large cohort from the Dog Aging Project.

Scientific reports·2025
Same author

[Anesthesia management in implantation of baroreceptor stimulators].

Der Anaesthesist·2015
Same author

Anthropological neurology: symptoms and their meanings according to Joseph Prick (1909-1978).

Journal of the history of the neurosciences·2011
Same author

Cardiac resynchronization therapy in patients with absent right but persistent left superior vena cava.

The Thoracic and cardiovascular surgeon·2009
Same author

[Not Available].

Herzschrittmachertherapie & Elektrophysiologie·2009
Same author

Pharmacotherapy of epilepsy: state of the art and developments.

Journal of clinical pharmacy and therapeutics·2009

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Ischaemic stroke poses a significant risk of recurrent brain infarction.
  • Secondary prevention strategies are crucial for managing patients at risk.

Purpose of the Study:

  • To review current literature on secondary prevention of ischaemic stroke.
  • To evaluate the efficacy of various pharmacological and surgical interventions.

Main Methods:

  • Literature review of clinical trials and meta-analyses.
  • Analysis of data on carotid endarterectomy, anticoagulant, and antiplatelet therapies.

Main Results:

  • Carotid endarterectomy benefits selected symptomatic patients with severe stenosis.
  • Acetylsalicylic acid provides a modest (15%) reduction in endpoints.
  • Combination therapy with dipyridamole may increase endpoint reduction to 30%.

Conclusions:

  • Antiplatelet agents, particularly acetylsalicylic acid, are key in secondary stroke prevention.
  • Ticlopidine offers an alternative for patients intolerant to acetylsalicylic acid, despite its own side effects.
  • Ongoing research aims to enhance drug treatment efficacy for ischaemic stroke prevention.

Related Experiment Videos